ELIZABETH A CUNNINGHAM

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health SPARTANBURG, SC NPI 1225627490

General Payments — all program years on this page

$3,046.24

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 183
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $393.17 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $365.9018
Education $27.271

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $480.5128
2022 $993.4059
2023 $1,179.1677
2024 $393.1719

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078179539 Janssen Pharmaceuticals, Inc $18.67 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078179633 Janssen Pharmaceuticals, Inc $18.05 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101271447 E.R. Squibb & Sons, L.L.C. $27.27 11/14/2024 Education Undisputed 01/23/2026 View at CMS
1101271453 E.R. Squibb & Sons, L.L.C. $20.84 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101271457 E.R. Squibb & Sons, L.L.C. $19.40 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106974263 ABBVIE INC. $16.94 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119053226 Otsuka America Pharmaceutical, Inc. $23.34 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133938012 Vanda Pharmaceuticals Inc. $19.58 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133938014 Vanda Pharmaceuticals Inc. $21.64 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143418450 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.76 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143418453 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.63 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143418457 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.80 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144548859 Indivior Inc. $13.87 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148356600 Axsome Therapeutics, Inc. $27.63 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150955393 Neurocrine Biosciences, Inc. $24.95 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150980004 Neurocrine Biosciences, Inc. $19.96 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151569077 Teva Pharmaceuticals USA, Inc. $29.17 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151569129 Teva Pharmaceuticals USA, Inc. $18.86 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151569169 Teva Pharmaceuticals USA, Inc. $14.81 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.